BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment

16 January 2023, Zwingenberg (Germany) - BRAIN Biotech, a leading provider of solutions for the biologization of industry, today presented its Annual Report 2021/22. With consolidated revenues of € 49.5 million and total operating performance of € 53.1 million in the reporting year, the Group recorded very encouraging growth of 29 % and 30 %, respectively, compared to the previous fiscal year and despite the challenging geopolitical environment. Without bottlenecks in the supply chain and logistic services, the company's growth could have been even more dynamic.